Wedge Capital Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $323K | Sell |
13,423
-1,562
| -10% | -$40.9K | 0.01% | 453 |
|
|
2026
Q1 | $421K | Sell |
14,985
-1,126,178
| -99% | -$30M | 0.01% | 480 |
|
|
2025
Q4 | $28.4M | Buy |
1,141,163
+84,924
| +8% | +$2.14M | 0.51% | 84 |
|
|
2025
Q3 | $26.9M | Sell |
1,056,239
-226,020
| -18% | -$5.58M | 0.46% | 84 |
|
|
2025
Q2 | $31.1M | Buy |
1,282,259
+24,736
| +2% | +$577K | 0.55% | 76 |
|
|
2025
Q1 | $31.9M | Buy |
1,257,523
+156,298
| +14% | +$4.09M | 0.62% | 79 |
|
|
2024
Q4 | $29.2M | Sell |
1,101,225
-13,976
| -1% | -$379K | 0.53% | 66 |
|
|
2024
Q3 | $32.3M | Sell |
1,115,201
-106,687
| -9% | -$3.11M | 0.56% | 70 |
|
|
2024
Q2 | $34.2M | Buy |
+1,221,888
| New | +$33.6M | 0.61% | 71 |
|
|
2024
Q1 | – | Sell |
-10,816
| Closed | -$311K | – | 518 |
|
|
2023
Q4 | $311K | Sell |
10,816
-49
| -0.5% | -$1.48K | 0.01% | 461 |
|
|
2023
Q3 | $360K | Buy |
10,865
+1,044
| +11% | +$36.9K | 0.01% | 459 |
|
|
2023
Q2 | $360K | Sell |
9,821
-275
| -3% | -$10.7K | 0.01% | 481 |
|
|
2023
Q1 | $412K | Buy |
10,096
+176
| +2% | +$7.6K | 0.01% | 328 |
|
|
2022
Q4 | $508K | Buy |
9,920
+153
| +2% | +$7.33K | 0.01% | 313 |
|
|
2022
Q3 | $427K | Sell |
9,767
-54
| -0.5% | -$2.62K | 0.01% | 318 |
|
|
2022
Q2 | $515K | Sell |
9,821
-653,411
| -99% | -$33.3M | 0.01% | 314 |
|
|
2022
Q1 | $34.3M | Buy |
663,232
+72,041
| +12% | +$3.74M | 0.46% | 85 |
|
|
2021
Q4 | $34.9M | Sell |
591,191
-90,818
| -13% | -$4.5M | 0.43% | 92 |
|
|
2021
Q3 | $29.3M | Sell |
682,009
-108,485
| -14% | -$4.81M | 0.38% | 108 |
|
|
2021
Q2 | $31M | Sell |
790,494
-109,415
| -12% | -$4.25M | 0.38% | 103 |
|
|
2021
Q1 | $32.6M | Buy |
899,909
+173,316
| +24% | +$6.15M | 0.39% | 99 |
|
|
2020
Q4 | $26.7M | Sell |
726,593
-60,869
| -8% | -$2.23M | 0.31% | 125 |
|
|
2020
Q3 | $27.4M | Sell |
787,462
-286,018
| -27% | -$10M | 0.37% | 87 |
|
|
2020
Q2 | $33.3M | Buy |
1,073,480
+3,223
| +0.3% | +$109K | 0.46% | 77 |
|
|
2020
Q1 | $33.1M | Sell |
1,070,257
-48,908
| -4% | -$1.67M | 0.57% | 63 |
|
|
2019
Q4 | $41.6M | Buy |
1,119,165
+1,106,666
| +8,854% | +$39.4M | 0.46% | 79 |
|
|
2019
Q3 | $426K | Sell |
12,499
-813,789
| -98% | -$29.6M | 0.01% | 427 |
|
|
2019
Q2 | $34M | Buy |
826,288
+817,693
| +9,514% | +$32.5M | 0.39% | 94 |
|
|
2019
Q1 | $346K | Sell |
8,595
-793,604
| -99% | -$31.8M | ﹤0.01% | 499 |
|
|
2018
Q4 | $33.2M | Sell |
802,199
-76,335
| -9% | -$3.17M | 0.41% | 79 |
|
|
2018
Q3 | $36.7M | Sell |
878,534
-12,649
| -1% | -$487K | 0.35% | 75 |
|
|
2018
Q2 | $30.7M | Sell |
891,183
-140,321
| -14% | -$4.8M | 0.3% | 101 |
|
|
2018
Q1 | $34.7M | Buy |
1,031,504
+1,024,334
| +14,286% | +$35.2M | 0.33% | 86 |
|
|
2017
Q4 | $246K | Buy |
7,170
+142
| +2% | +$4.84K | ﹤0.01% | 555 |
|
|
2017
Q3 | $238K | Buy |
7,028
+318
| +5% | +$10.2K | ﹤0.01% | 552 |
|
|
2017
Q2 | $214K | Buy |
+6,710
| New | +$212K | ﹤0.01% | 551 |
|
|
2017
Q1 | – | Sell |
-1,724,016
| Closed | -$53.1M | – | 576 |
|
|
2016
Q4 | $53.1M | Buy |
1,724,016
+201,699
| +13% | +$6.16M | 0.52% | 48 |
|
|
2016
Q3 | $48.9M | Buy |
1,522,317
+63,792
| +4% | +$2.13M | 0.49% | 61 |
|
|
2016
Q2 | $48.7M | Sell |
1,458,525
-4,212
| -0.3% | -$134K | 0.5% | 58 |
|
|
2016
Q1 | $41.1M | Buy |
1,462,737
+228,371
| +19% | +$6.52M | 0.43% | 60 |
|
|
2015
Q4 | $37.8M | Sell |
1,234,366
-46,666
| -4% | -$1.47M | 0.4% | 86 |
|
|
2015
Q3 | $38.2M | Sell |
1,281,032
-55,493
| -4% | -$1.78M | 0.4% | 69 |
|
|
2015
Q2 | $42.5M | Sell |
1,336,525
-269,297
| -17% | -$8.78M | 0.41% | 86 |
|
|
2015
Q1 | $53M | Sell |
1,605,822
-65,616
| -4% | -$2.09M | 0.53% | 53 |
|
|
2014
Q4 | $49.4M | Buy |
1,671,438
+229,308
| +16% | +$6.58M | 0.5% | 63 |
|
|
2014
Q3 | $40.5M | Sell |
1,442,130
-251,601
| -15% | -$7.06M | 0.43% | 75 |
|
|
2014
Q2 | $47.7M | Buy |
1,693,731
+113,126
| +7% | +$3.22M | 0.49% | 64 |
|
|
2014
Q1 | $48.2M | Buy |
1,580,605
+109,643
| +7% | +$3.27M | 0.51% | 62 |
|
|
2013
Q4 | $42.7M | Buy |
1,470,962
+50,539
| +4% | +$1.47M | 0.45% | 82 |
|
|
2013
Q3 | $38.7M | Buy |
1,420,423
+122,849
| +9% | +$3.34M | 0.45% | 77 |
|
|
2013
Q2 | $34.5M | Buy |
+1,297,574
| New | +$35.9M | 0.41% | 94 |
|
Other funds holding PFE
Wedge Capital Management's PFE Position: Q2 2026 in Review
Wedge Capital Management reduced its Pfizer (PFE) stake by 10% in Q2 2026, selling an estimated $40.9K and leaving 13,423 shares worth $323K. The position accounts for 0.01% of the portfolio, ranked #453.
Wedge Capital Management first reported a position in PFE in Q2 2013 and has held it in 51 quarters since. The position peaked at $53.1M in Q4 2016. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Wedge Capital Management held 13,423 shares of Pfizer worth $323K as of Q2 2026.
- Wedge Capital Management sold 1,562 Pfizer shares in Q2 2026, an estimated $40.9K.
- Pfizer made up 0.01% of Wedge Capital Management's portfolio in Q2 2026, its #453 holding.
- Wedge Capital Management first reported a position in Pfizer in Q2 2013 and has held it in 51 quarters since.
- Wedge Capital Management's Pfizer position peaked at $53.1M in Q4 2016.
- 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Wedge Capital Management's 13F filing for Q2 2026, filed 10 Jul 2026.